AMPLIFON IS A GLOBAL TOP EMPLOYER 2026
Only 17 companies worldwide have earned this recognition for their human resources management practices in 2026. Certification obtained for the first time in the Asia-Pacific region, together with confirmation in Europe, North America, and Latin America. Switzerland, India, China, and Singapore were also certified for the first time MILAN, Jan. 15, 2026...
XA Africa Rebrands to A54, Signaling a New Era for African Tech Investment
The rebranding signals a sharper focus on the African continent for this exclusive angel investor network SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- XA Africa, the exclusive operator-led investment network founded by global technology veterans, today announced its official launch as A54. The rebrand marks a significant milestone in the network's evolution, reflecting its deepened commitment to the 54 nations...
GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities
YONGIN, South Korea, Jan. 15, 2026 /PRNewswire/ -- GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to...
Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand and optimize engagements with healthcare professional (HCP) audiences. Backed by real-world insights from Docquity's network of more than 500,000 verified doctors across Asia, Docquity Engage™ provides...
Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease
SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AB-1009, an investigational adeno-associated virus (AAV) gene therapy being developed for the treatment of late-onset...
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients Complex modalities are WuXi Biologics' core growth engine, with 2/3 of the new integrated projects comprising bispecific/multispecific antibodies and ADCs Bispecific/multispecific antibodies are...
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral ‘XAFTY’ Following 2026 Biotech Showcase Consensus
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the same drug. - Dr. Davey Smith: "With this multi-virus treatment, 2026 may mark...
International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach
BANGKOK, Jan. 15, 2026 /PRNewswire/ -- International Healthcare Week is set to return to Thailand (8-10 July 2026, Queen Sirikit National Convention Center, Bangkok), bringing together the region's most influential health and wellness stakeholders. Organised by Informa Markets, this flagship event will co-locate three major exhibitions: CPHI South East Asia, WHX Bangkok (formerly Medlab Asia and Asia Health), and Medtec...
HNC Expo 2025 Concluded Successfully in Shenzhen, Next Stop Shanghai in June 2026
SHENZHEN, China, Jan. 15, 2026 /PRNewswire/ -- During December 16-18, 2025, the "Healthplex Expo, Natural & Nutraceutical Products Shenzhen" (HNC Shenzhen), co-organized by CCCMHPIE and Sinoexpo Informa Markets, was held successfully at the Shenzhen World Exhibition & Convention Center. With Shenzhen as its anchor city, the exhibition fully leveraged the Greater Bay Area's industrial concentration to create a professional...
AIM’s Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products
HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed the Phase III clinical site work. This marks the official entry of the vaccine into a new phase, laying a solid foundation for future...
